Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biochemical and Biophysical Research Communications|January 22, 2017
Antitumor activity of a novel and orally available inhibitor of serine palmitoyltransferaseMasahiro Yaguchi, Sachio Shibata, Yoshinori Satomi, et al.
Bioorganic & Medicinal Chemistry|February 9, 2017
Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF<sub>1</sub> receptor antagonistMichiyo Mochizuki, Takuto Kojima, Katsumi Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 14, 2012
[A case of endocrine cell carcinoma of the esophagus successfully treated by chemoradiotherapy]Takayuki Murase, Takuma Higurashi, Soutaro Akatsuka, et al.
Digestion|November 2, 2011
Capsule-endoscopic findings of ulcerative colitis patientsTakuma Higurashi, Hiroki Endo, Masato Yoneda, et al.
Bioorganic & Medicinal Chemistry|February 21, 2018
Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonistsTakuto Kojima, Michiyo Mochizuki, Takafumi Takai, et al.
ACS Medicinal Chemistry Letters|October 15, 2025
Discovery of Rogocekib (CTX-712): A Potent and Selective CLK Inhibitor for Cancer TreatmentYouichi Kawakita, Takuto Kojima, Noriyuki Nii, et al.
Bioorganic & Medicinal Chemistry|April 20, 2018
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agentsTakuto Kojima, Yasutomi Asano, Osamu Kurasawa, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding ModeJun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Pageof 2